现已上线！2025 年 Telegram 研究 — 年度关键洞察 
Internal medicine hub
前往频道在 Telegram
IM tips & Q-bank for SMLE and part https://tellonym.me/user.IMhub/nhie Ask me here: @llqkq
显示更多1 130
订阅者
-124 小时
-27 天
+1030 天
帖子存档
16 year old patient presented with cyanosis and lower extremity clubbing only. Which of the following is true?
Hypokalemia and HTN:
1- Hyperaldosteronism
2- Liddles syndrome
3- Cushing
Hypokalemia and hypo/normotensive:
1- Bartters syndrome (associated with kidney stone)
2- Gitelmans syndrome (associated with low Mg)
Which one of the following is a cause of hypertension and hypokalemia?
Think of 👀
- Mesenteric thrombus: think of PNH
- splenic/hepatic/portal thrombus: think of JAK2 mutation
- thrombosis and bleeding: thinks of dysfibrinogenemia
- venous & arterial thrombosis: think of Hyperhomocysteinemia, Antiphospholipid syndrom or dysfibrinogenemia
السلام عليكم
حرصًا على تطوير هذه القناة وتقديم أفضل دعم لكم أود إعلامكم بأنني متواجد للإجابة على أي استفسار يخص التجميعات أو لتوضيح أي سؤال غير واضح
التواصل معي على الرابط بالأسفل
هدفي هو أن تكون القناة مصدرًا موثوقًا ومفيدًا للجميع
https://tellonym.me/user.IMhub/nhie
💡 Explanation:
This is Brucella Spondylitis: management is Doxycycline and Rifampin for 12 weeks PLUS:
- Streptomycin for 14-21 days
- Gentamicin for 7-10 days
Otherwise standard regimens include Doxycycline for 6 weeks plus one of the following:
- Streptomycin for 14-21 days
- Gentamicin for 7-10 days
- Rifampin for 6 weeks
Rifampin and Doxycycline is the only fully oral regimen of the above but aminoglycoside containing regimens are preferred
40 Y/O male with a history of cattle exposure present with fever, low back pain and headache for 1m. Imaging reveals sacroilitis, gram stain: G-ve coccobacilli
What is the most appropriate treatment?
In patients with a low-risk aPL profle, who had frst venous thrombosis in the presence of a known transient risk factor, anticoagulation could be limited to 3–6 months
COPD patient with FEV1 of 38% based on GOLD classification which class of severity is this patient?
💡 Systemic scleroderma tips:
- 40% of patient with SS & SRC progress to ESRD (even with ACEi)
- risk increase with; early disease, diffuse cutaneous SS, >15mg/d pred and RNA Pol III Ab
Scleroderma Ddx:
- Scleromyxedema
- Hypothyroidism
- Nephrogenic systemic fibrosis
- Esinophilic fasciitis
- Amyloidosis
- GVHD
- Diabetes scleredema
🌍 Epidemiology:
- 20-30% of psoriasis patients develop arthritis
- 20% of IBD patients develop IBD associated arthritis (CD > UC)
Ddx of ESR more than 100:
- malignancy (MM & lymphoma)
- vasculitis (GCA)
- endocarditis
- TB
- OM
